Eledon Pharmaceuticals, Inc. Common Stock (ELDN) Stock Price

ELDNStock
$3.47+31.15%52W
Market Cap$281.98M
P/E
PEG Ratio
Div yield
Beta0.88

ELDN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)51.13%
Price vs S&P 500 (4W)-2.76%
VGM Score49.91

ELDN Earnings Surprise History

Q2 25-0.13est. -0.23
Q3 25-0.21est. -0.25
Q4 25-0.10est. -0.20
Q1 26-0.33est. -0.23
Q2 26-0.27est. -0.15

ELDN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.23
4.25
4.25
4.25

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ELDNEledon Pharmaceuticals, Inc. Common Stock
C$3.47
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Eledon Pharmaceuticals, Inc. Common Stock

Eledon Pharmaceuticals is a clinical-stage biotech company developing tegoprubart, an anti-CD40L antibody targeting a well-validated pathway with broad therapeutic potential. The company is pursuing applications across transplantation, autoimmune diseases, and ALS, addressing significant unmet medical needs in each indication.